Avenacy
Jeffrey Yordon has diverse work experience in various leadership roles. Jeffrey currently serves as the Chief Executive Officer of Avenacy. Prior to this, they held the position of Chairman of the Board at the Northern Illinois University Foundation Board, where they focused on developing and supporting a culture of giving within the NIU community. Yordon also served as a Board Member and Vice Chairman/Secretary at the Illinois Sports Facility Authority, overseeing the operation and maintenance of sports facilities. In addition, they worked as the President and Chief Operating Officer of Athenex Pharma, a commercial company of Athenex Pharmaceuticals, where they drove the company's growth through acquisitions, partnerships, and product development agreements. Previously, Yordon founded Sagent Pharmaceuticals and served as its Chairman and CEO before relinquishing their role in 2014.
Jeffrey Yordon attended Northern Illinois University from 1966 to 1970, earning a Bachelor's degree in Political Science and Marketing.
This person is not in any teams
Avenacy
Avenacy is a rapidly growing U.S.-based specialty pharmaceutical company focused on providing critical injectable medications used to treat patients in various medically supervised settings, from acute care hospitals to outpatient clinics and physician offices. Through a rigorous and optimized selection process, the Company is building out a pipeline of high-quality FDA approved injectable products to ensure a resilient portfolio that can meet the needs of today’s dynamic drug supply chain. With an experienced team, commitment to quality and reliability, and product offerings intended to facilitate safe and efficient patient care, Avenacy strives to be a trusted partner for essential injectable medications.